Operating Lease, Liability, Current in USD of Lyell Immunopharma, Inc. from Q4 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Summary
Lyell Immunopharma, Inc. quarterly Operating Lease, Liability, Current history and change rate from Q4 2020 to Q3 2025.
  • Lyell Immunopharma, Inc. Operating Lease, Liability, Current for the quarter ending 30 Sep 2025 was $8,788,000.000, a 23.2% increase year-over-year.
Operating Lease, Liability, Current, Quarterly (USD)
Operating Lease, Liability, Current, YoY Quarterly Change (%)

Lyell Immunopharma, Inc. Quarterly Operating Lease, Liability, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $8,788,000 +$1,654,000 +23.2% 30 Sep 2025 10-Q 12 Nov 2025
Q2 2025 $8,510,000 +$1,612,000 +23.4% 30 Jun 2025 10-Q 12 Aug 2025
Q1 2025 $8,238,000 +$1,571,000 +23.6% 31 Mar 2025 10-Q 13 May 2025
Q4 2024 $7,974,000 +$1,701,000 +27.1% 31 Dec 2024 10-K 11 Mar 2025
Q3 2024 $7,134,000 +$1,073,000 +17.7% 30 Sep 2024 10-Q 07 Nov 2024
Q2 2024 $6,898,000 +$1,045,000 +17.9% 30 Jun 2024 10-Q 07 Aug 2024
Q1 2024 $6,667,000 +$1,857,000 +38.6% 31 Mar 2024 10-Q 06 May 2024
Q4 2023 $6,273,000 +$1,739,000 +38.4% 31 Dec 2023 10-K 11 Mar 2025
Q3 2023 $6,061,000 +$3,222,000 +1.1% 30 Sep 2023 10-Q 07 Nov 2023
Q2 2023 $5,853,000 +$4,377,000 +3% 30 Jun 2023 10-Q 08 Aug 2023
Q1 2023 $4,810,000 +$3,471,000 +2.6% 31 Mar 2023 10-Q 04 May 2023
Q4 2022 $4,534,000 +$3,365,000 +2.9% 31 Dec 2022 10-K 28 Feb 2024
Q3 2022 $2,839,000 30 Sep 2022 10-Q 08 Nov 2022
Q2 2022 $1,476,000 30 Jun 2022 10-Q 04 Aug 2022
Q1 2022 $1,339,000 31 Mar 2022 10-Q 10 May 2022
Q4 2021 $1,169,000 -$2,448,000 -67.7% 31 Dec 2021 10-K 28 Feb 2023
Q4 2020 $3,617,000 31 Dec 2020 10-K 29 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.